Clinical trials: New Imaging Modality
Cancer
Hybrid PET/CT in Cancer Patients
The purpose of the present study is to assess the role of hybrid PET/CT imaging diagnosis of active malignancy in cancer patients with rising tumor markers after treatment and in the diagnosis of primary tumor in patients with…
- Trial name
- NCT00396916
- Testing
- PET/CT imaging
- Where
- Israel
- Volunteers
- 45 people
- Sponsor
- Rambam Health Care Campus
Image-Guided Biopsies and/or Ablations
Comparison of a Novel Ultrasound System Versus Standard Imaging Modalities
This is an observational study comparing a novel ultrasound-based imaging system (MAUI K3900) to standard-of-care (SoC) imaging systems used to guide and/or manage interventional radiologic procedures such as solid organ biopsies…
- Trial name
- NCT05748106
- Testing
- Ultrasound-based imaging
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- MAUI Imaging, Inc.
Neurofibromatosis Type 1, Precancerous Condition
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
RATIONALE: New imaging procedures such as fludeoxyglucose F 18 positron emission tomography (FDG-PET) and magnetic resonance (MR) perfusion imaging may improve the ability to detect disease progression, help doctors predict a…
- Trial name
- NCT00060008
- Testing
- fludeoxyglucose F 18, gadopentetate dimeglumine
- Where
- 2 sites in United States
- Volunteers
- 18 people
- Sponsor
- Children's Hospital of Philadelphia